{"disease":{"id":"influenza-vaccines","name":"influenza vaccines"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03666026","title":"Patient Portal - Flu Reminder Recall","phase":"NA","overall_status":"COMPLETED","enrollment_count":164205,"lead_sponsor_name":"University of California, Los Angeles","has_results":true},{"nct_id":"NCT02924467","title":"Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates in New York State","phase":"NA","overall_status":"COMPLETED","enrollment_count":100000,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT03294473","title":"Centralized Reminder Recall - Flu RCT2","phase":"NA","overall_status":"COMPLETED","enrollment_count":70190,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT02761551","title":"Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates","phase":"NA","overall_status":"COMPLETED","enrollment_count":56549,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT03246100","title":"Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates_2nd Trial in Colorado","phase":"NA","overall_status":"COMPLETED","enrollment_count":25531,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT07161739","title":"Vaccination Nudges From Pharmacists","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20000,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT03734237","title":"A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":15448,"lead_sponsor_name":"Henry M. Jackson Foundation for the Advancement of Military Medicine","has_results":true},{"nct_id":"NCT04038333","title":"Financing Strategies of Influenza Vaccination in China","phase":"","overall_status":"COMPLETED","enrollment_count":13542,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT05298800","title":"Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Centers for Disease Control and Prevention, China","has_results":false},{"nct_id":"NCT05521763","title":"Influenza Vaccine Uptake Among Healthcare Workers","phase":"NA","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"International Centre for Diarrhoeal Disease Research, Bangladesh","has_results":false},{"nct_id":"NCT00325156","title":"Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2590,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05494047","title":"Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":1600,"lead_sponsor_name":"Pontificia Universidad Catolica de Chile","has_results":false},{"nct_id":"NCT00449670","title":"Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1206,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06657573","title":"Vaccine Chatbot for Improving Influenza Vaccination Uptake","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05470582","title":"Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1066,"lead_sponsor_name":"St. Petersburg Research Institute of Vaccines and Sera","has_results":false},{"nct_id":"NCT00586469","title":"A Randomized Study to Compare the Safety and Immunogenicity of Fluviral® Made With New Versus Aged Bulk","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01310413","title":"Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":842,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02422264","title":"Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":601,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02853929","title":"Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":551,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03057483","title":"Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute","phase":"","overall_status":"COMPLETED","enrollment_count":533,"lead_sponsor_name":"Butantan Institute","has_results":false},{"nct_id":"NCT00430521","title":"Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":512,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03392207","title":"Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)","phase":"","overall_status":"COMPLETED","enrollment_count":403,"lead_sponsor_name":"Butantan Institute","has_results":false},{"nct_id":"NCT00306995","title":"Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":385,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01577732","title":"Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":321,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01106092","title":"Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":312,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06259487","title":"Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Wroclaw Medical University","has_results":false},{"nct_id":"NCT01353703","title":"Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":224,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05457894","title":"Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine] in Pregnant Women","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":207,"lead_sponsor_name":"St. Petersburg Research Institute of Vaccines and Sera","has_results":false},{"nct_id":"NCT06676644","title":"Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-adjuvanted Vaccines","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT06179446","title":"A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":157,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT00718120","title":"Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05401305","title":"Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"St. Petersburg Research Institute of Vaccines and Sera","has_results":false},{"nct_id":"NCT01358825","title":"Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01788228","title":"Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03735147","title":"Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Imperial College London","has_results":true},{"nct_id":"NCT01195779","title":"Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"GlaxoSmithKline","has_results":true}],"total":36},"guidelines":[],"source":"Drug Landscape verified database"}